Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols
No abstract listed.
Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma
A risky business: the detection of adverse drug reactions in clinical trials and post-marketing exercises
International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992
A comparison of the death rates from asthma 1953-67 for the age groups 10-14, 15-19, and 20-24 in England and Wales with those for the same age groups in Sweden. Why have mortality rates for asthma, particularly in the mid-1960s, been higher in England and Wales than in Sweden?
Tolerance to sympathomimetic bronchodilators in guinea-pig isolated lungs following chronic administration in vivo
Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays?
Identification of adverse reactions to new drugs. II (continued): How were 18 important adverse reactions discovered and with what delays?
Adjustment for the influence of age and heart rate on Doppler measurements of left ventricular filling
A survey of asthma mortality in patients between ages 35 and 64 in the Greater London hospitals in 1971
Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects
Death due to asthma. New insights into sudden unexpected deaths, but the focus remains on prevention
Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene
Multi-centre clinical trial of nedocromil sodium in reversible obstructive airways disease in adults: a general practitioner collaborative study
International trends in asthma mortality rates in the 5- to 34-year age group: a call for closer surveillance
Evidence of tachyphylaxis associated with salmeterol treatment of chronic obstructive pulmonary disease patients
Comparison of the cardiopulmonary effects of subcutaneously administered epinephrine and terbutaline in patients with reversible airway obstruction
Acquired resistance to beta stimulants: a possible explantion for the rise in the asthma death rate in Britain
Age- and gender-specific asthma death rates in patients taking long-acting beta2-agonists: prescription event monitoring pharmacosurveillance studies
Effects of the β-agonist, isoprenaline, on the down-regulation, functional responsiveness and trafficking of β2-adrenergic receptors with N-terminal polymorphisms
Albuterol: an adrenergic agent for use in the treatment of asthma pharmacology, pharmacokinetics and clinical use
A primer of drug safety surveillance: an industry perspective. Part I: Information flow, new drug development, and federal regulations
Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II)
A primer of drug safety surveillance: an industry perspective. Part II: Product labeling and product knowledge
This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.
Allergy and Asthma
Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.